Target intelligence / Profile preview

O-antigen polysaccharide of Salmonella typhimurium lipopolysaccharide (O-antigen)

Target
O-antigen
Molecular classification
Polysaccharide, Bacterial surface antigen, Lipopolysaccharide component
01

Overview

The O-antigen polysaccharide is the outermost, highly variable component of the lipopolysaccharide (LPS) complex located on the surface of Salmonella enterica serovar Typhimurium. It consists of repeating oligosaccharide units—typically comprising D-galactose, L-rhamnose, and D-mannose with an abequose side chain—that determine the bacterium's O-serogroup identity (Raetz & Whitfield, 2002). Biologically, the O-antigen serves as a critical virulence factor by protecting the pathogen from host innate immune defenses, such as complement-mediated lysis and phagocytosis, and by providing resistance to environmental stressors like bile (Hajra et al., 2021). In the context of drug development, the O-antigen is a primary target for glycoconjugate vaccines and therapeutic monoclonal antibodies designed to combat non-typhoidal Salmonella (NTS) infections (Micoli et al., 2018). These therapeutic strategies aim to elicit high-affinity antibodies that promote opsonophagocytosis and bacterial killing. However, the structural diversity of O-antigens across different serovars remains a significant challenge for creating broad-spectrum protective interventions (MacLennan et al., 2014).

Other names
O-polysaccharideO-side chainSomatic O-antigenLPS O-antigenSalmonella Typhimurium O-antigen
02

Mechanism of action

Induction of opsonophagocytic and bactericidal antibodies that facilitate bacterial clearance by the immune system; neutralization of bacterial attachment and colonization.

03

Biological functions

Immune evasionProtection against complement-mediated killingResistance to serum bactericidal activityStructural integrity of the outer membraneBile resistanceSerotype specificity
04

Disease associations

InfectionSalmonellosisGastroenteritisSepsisFood poisoning
05

Safety considerations

Endotoxicity (if associated with Lipid A)Serotype-specific protection (lack of cross-reactivity with other Salmonella serovars)Potential for O-antigen phase variation or loss (rough mutants) leading to immune escapeHypersensitivity to vaccine components
06

Interacting drugs

O-antigen-CRM197 conjugate vaccine

4 more in the full profile.

07

Biomarkers

Anti-O-antigen IgG antibody titerAnti-O-antigen IgM antibody titerO-antigen detection in stool or blood samples

Beyond the preview

Go deeper on O-antigen polysaccharide of Salmonella typhimurium lipopolysaccharide (O-antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on O-antigen polysaccharide of Salmonella typhimurium lipopolysaccharide (O-antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call